![References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/05cd30fa-05ac-458c-8f1a-ab4b0e61d988/gr2_lrg.jpg)
References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology
![Sustained-release Naltrexone/Bupropion—A Novel Pharmacologic Approach to Obesity and Food Craving – touchENDOCRINOLOGY Sustained-release Naltrexone/Bupropion—A Novel Pharmacologic Approach to Obesity and Food Craving – touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2015/08/percent_change.png)
Sustained-release Naltrexone/Bupropion—A Novel Pharmacologic Approach to Obesity and Food Craving – touchENDOCRINOLOGY
![Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes | Future Cardiology Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca.15.79/asset/images/medium/figure1.gif)
Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes | Future Cardiology
![Advances in Pharmacotherapy with a Focus on Combination Therapy Louis J. Aronne, MD, FACP Clinical Professor of Medicine Weill Cornell Medical College. - ppt download Advances in Pharmacotherapy with a Focus on Combination Therapy Louis J. Aronne, MD, FACP Clinical Professor of Medicine Weill Cornell Medical College. - ppt download](https://images.slideplayer.com/11/3274974/slides/slide_14.jpg)
Advances in Pharmacotherapy with a Focus on Combination Therapy Louis J. Aronne, MD, FACP Clinical Professor of Medicine Weill Cornell Medical College. - ppt download
![Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661814000449-gr2.jpg)
Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect
![Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661814000449-gr4.gif)
Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect
![Frontiers | A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss | Pharmacology Frontiers | A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss | Pharmacology](https://www.frontiersin.org/files/Articles/611361/fphar-11-611361-HTML/image_m/fphar-11-611361-g001.jpg)
Frontiers | A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss | Pharmacology
![References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/746a6454-ed6d-4207-a439-b4d28a3addf1/gr1_lrg.jpg)
References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology
![Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/57a735cf-b3d7-469a-b200-aba14241d911/gr2.jpg)
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
![Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661814000449-fx1.jpg)